Roeland Wasmann

22PUBLICATIONS
69CO-AUTHORS
Gene and molecular therapyAdolescent healthStochastic analysis and modellingInfant and child healthPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Dec 30, 2025
Pharmacokinetics of Twice-daily Tenofovir Alafenamide in Adults With HIV-associated Tuberculosis on Bictegravir/Emtricitabine/Tenofovir Alafenamide and Rifampicin.

Emmanuella Chinonso Osuala, Ivan Nicholas Nkuhairwe, Marothi Peter Letsoalo

|Sep 26, 2025
Population pharmacokinetics of ritonavir as a booster of lopinavir, atazanavir, or darunavir in African children with HIV.

Lufina Tsirizani, Hylke Waalewijn, Alexander Szubert

|Mar 11, 2025
A Pragmatic Approach to Handling Censored Data Below the Lower Limit of Quantification in Pharmacokinetic Modeling.

Marie Wijk, Roeland E Wasmann, Karen R Jacobson

|Sep 20, 2024
Pharmacokinetics of once-daily darunavir/ritonavir in second-line treatment in African children with HIV.

Lufina Tsirizani, Shaghayegh Mohsenian Naghani, Hylke Waalewijn

|Jul 27, 2024
Population Pharmacokinetics of Dolutegravir in African Children: Results From the CHAPAS-4 Trial.

Hylke Waalewijn, Roeland E Wasmann, Alasdair Bamford

|Jul 04, 2024
Dose optimization of cefazolin in South African children undergoing cardiac surgery with cardiopulmonary bypass.

Manna Semere Gebreyesus, Alexandra Dresner, Lubbe Wiesner

Pageof 4